NASDAQ:ENGN | EBITDA | enGene Therapeutics Inc.

Complete source-backed ebitda history.

Available history
2022-10-31 to 2026-04-30
Data captured

Historical EBITDA

DateEBITDA
2026-04-30-$31.77M
2026-01-31-$31M
2025-10-31-$39.28M
2025-07-31-$29.85M
2025-04-30-$27.02M
2025-01-31-$26.51M
2024-10-31-$17.36M
2024-07-31-$16.66M
2024-04-30-$17.21M
2024-01-31-$10.69M
2023-10-31-$10.37M
2023-07-31-$6.21M
2023-04-30-$4.7M
2023-01-31-$4.59M

Annual EBITDA

DateEBITDA
2025-10-31-$122.67M
2024-10-31-$62M
2023-10-31-$25.86M
2022-10-31-$19.23M